It is well established that the overexpression of IL-17A exacerbates DR-like pathology by decreasing the function of Müller cells, promoting retinal endothelial cell and retinal ganglion cell death, leading to retinal inflammation, oxidative stress, and vascular permeability in DM animals [10,11,25–27]. Here, IL17A is linked to diabetes mellitus.